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Summary
Background. Peripheral arterial diseases in patients with diabetic foot (PAD/DF) have significant 
differences in pathogenesis, manifestations and course compared with peripheral arterial diseases 
(PAD). These differences cause creating classifications to access severity PAD/DF and PAD sepa-
rately. But approaches to revascularizations in PAD/DF and PAD remain the same. The choice of 
revascularization method taking into account the features can significantly improve its results.
Aim: to determine specific features of peripheral arterial diseases in patients with diabetic foot that 
influence the choice of revascularization method.
Material and methods. We analyzed results of 98 revascularizations of 77 lower extremities in 
74 patients in the period from 2014 to 2019. Angioplasties were performed 72,3%, open operations – 
21,4%, hybrid procedures 6,1%.
Results. Amputation-free survival during the year was 84,6%. Healing of trophic disorders during 
the year was 70,5%.
Conclusions. At the diagnostic stage, patients with PAD and PAD / DF should be separated for 
creating the optimal treatment plan and the choice of revascularization technique. Different ap-
proaches to the PAD/DF patients can improve the results of revascularizations.
Key words: peripheral arterial diseases, diabetic foot, angiosome-targeted revascularization, 
angioplasty
INTRODUCTION
PAD of the lower extremities are common age-re-
lated pathology which significantly impair the quality of 
life and lead to disability of people over 50 years. In the 
trial PARTNERS (PAD, Awareness, Risk and Treatment: 
New Resources for Survival) were examined 6979 people 
over 50 years in 320 clinics (USA). PAD were found in 
29% (1865 patients) [1].
Diabetics are 2.7 times more prone to peripheral 
artery disease than people of the same age without dia-
betes [2].
The probability of large amputation in PAD/DF is 
six times higher than in non-diabetics [3].
Amputation-free survival as an important factor 
of the lifetime.
The results of a multicenter randomized BASIL study 
were published in 2010. The results of revascularization in 
452 patients with severe ischemia of the lower extremity 
were analyzed, the monitoring period was 3 years. Open 
interventions were performed 228, endovascular inter-
ventions – 224.
50-90% of patients survived for 2 years. The large 
discrepancy is due to risk factors: old age, overweight, di-
abetes, renal failure, arteries below the knee, and so on.
172 patients (38%) escaped high amputation By the 
end of the follow-up period – 3 years – 202 (45%) of which 
survived. That is, 84.4% of the survivors were patients 
whose limb was saved. The authors of the study empha-
size the need for a differentiated approach to the choice 
of revascularization techniques taking into account risk 
factors [4].
Mortality after major amputation is significantly 
higher for patients with diabetes compared to non-dia-
betes patients. At the first week mortality rate was 30% 
for diabetes patients versus 8% non-diabetes patients, at 
1 year 80% versus 57% [5].
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PATHOMORPHOLOGICAL FEATURES PAD/DF
Typical localisation of artery lesions in PAD/DF:
According to the literature the arteries lesions in di-
abetes are localized in below-the-knee arteries in 74% [6].
According to our data, hemodynamically significant 
lesions in below-the-knee arteries were found in 83.33% 
of cases.
Microangiopathy: DM is characterized by patho-
logical changes in the arterioles and capillaries thickening, 
which is another factor that impairs the trophism of the 
tissue of the foot. Microangiopathy is an additional factor 
that enlarges tissue ischemia of the foot and speeds up the 
development of necrotic changes.
Neuropathy and PAD/DF: One of the leading fac-
tors in the development of PAD /DF, in addition to those 
mentioned above, is diabetic neuropathy. The common 
consequences of neuropathy are the absence of pain, re-
duced local tissue response, impaired human behavioral 
response to tissue damages.
Neuropathy affects pathological changes in the arte-
rial wall. The damage to the autonomic innervation of the 
arterial wall causes dysfunction of myocytes, their transfor-
mation into connective tissue cells, replacement of myo-
cytes with connective tissue, which leads to the formation 
of atherosclerotic plaques [7].
Mediacalcinosis is typical for diabetic lesions of the 
arterial wall and is also a consequence of neuropathy. Nor-
mally, vascular smooth muscle cells under the influence 
of sympathetic innervation produce inhibitors of calcium 
uptake and retention. In diabetic neuropathy, sympathetic 
nerve damage inhibits the synthesis of calcification inhib-
itors and promotes calcium deposition in the middle layer 
of the arterial wall [8].
Dependence of diabetic neuropathy on PAD. In a cohort 
study by E. Faglia et al. [9]. Angiography was performed on 
567 diabetics with signs of critical foot ischemia (trophic 
disorders, pain at rest) to diagnose arterial lesions. Ac-
cording to her results, out of 567, only 3 patients did not 
have hemodynamically significant (> 50% of the lumen) 
stenoses of the arteries of the lower extremities.
Infection: A pathological state caused by invasion 
and multiplication of microorganisms in host tissues ac-
companied by tissue destruction and/or a host inflam-
matory response. Typical progression of the diabetic foot 
infection is in the IDSA/IWGDF [10].
Studies of the amputated limb arteries have 
shown infection of atherosclerotic plaques much prox-
imal to the area of  trophic lesions of the foot and leg. 
The authors suggest that the accession of bacterial infection 
of the walls of arteries or atherosclerotic plaques may be 
a synergistic factor that worsens the course of the disease 
and leads to amputation of the limb faster [11].
PAD AND PAD/DF CLASSIFICATIONS
The correct choice of classification allows to ade-
quately assess the clinical case and choose the right treat-
ment tactics
Confusion due to the use of several classification sys-
tems prevents the development of optimal treatment algo-
rithms for patients with chronic lower extremity ischemia [12]
The main clinical signs of PAD are given in the most 
common classifications Fontain and Rutherford.
In cases PAD without diabetes the main symptom 
is intermitten claudication. Foot trophic disorders are 
considered signs of the last stages before the threat of the 
loss of the limb.
Fontain classification.
І ст. Asymptomatic, incomplete blood vessel obstruction.
ІІ ст. Mild claudication pain in limb.
ІІа. Claudication at a distance < 200 m
ІІб. Claudication at a distance < 200 m
ІІІ ст. Rest pain, mostly in the feet
IV ст. Necrosis and/or gangrene of the limb.
The classification is based on the patient’s sub-
jective assessment of the pain syndrome, the objective 
signs – necrotic changes – are assessed only at the last 
stage.  Rutherford’s classification is similar in principle, 
but uses the ankle- shoulder index as an objective criterion.
PAD/DF: COMPARATIVE FEATURES
When combining PAD and diabetes mellitus, the de-
velopment and manifestations of ischemia are significantly 
influenced by the above pathogenetic factors.
Infection, ulceration or destruction of tissues of the 
foot associated with neuropathy and/or peripheral artery 
disease in the lower extremity of a person with (a history 
of) diabetes mellitus [10].
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In PAD/DF, unlike PAD, trophic changes of the 
lower leg and foot in the form of ulcers and focal necrosis 
may be only the beginning of the disease, ischemia is not 
always a mandatory component. 
Correct assessment of the severity of tissue damage, 
the influence of certain pathogenetic factors required de-
tailed classifications.
Modern classifications recommended by the Inter-
national Working Group of Diabetic Foot [10] – WIFi, 
IWGDF/IDSA and SYNBAD.






Middlefoot or hitefoot 1
Ischemia
Pedal blood flow intact: at least one palpable pulse 0
Clinical evidence of reduced pedal flow 1
Neuropathia
Protective sensation intact 0
Protective sensation lost 1
Bacterial infection None 0
Present 1
Area Ulcer < 1 sm 0
Ulcer > 1 sm 1
Depth Ulcer confined to skin and subcutaneous tissue 0
Ulcer reaching muscle, tendon or deeper 1
Total 6
So a small uninfected trophic ulcer gains 0-1 
points in contrast to the Fontain classification, ac-
cording to which trophic changes correspond to stage 
IV, the most severe. To assess the severity of the infec-
tious process IWGDF/IDSA System is recommended. 
WIfI system classification is recommended for a com-
prehensive assessment of the severity of the foot and 
treatment prospects
WIfI system: Wound, Ischemia, Foot infection
Wound 
grade Diabetic foot ulcer (DFU) Gangrene
0
No ulcer No gangrene
Clinical description: minor tissue loss. Salvageable with simple digital amputation (1 or 2 digits) or skin coverage.
1
Small, shallow ulcer(s) on distal leg or foot; no
exposed bone, unless limited to distal phalanx
No gangrene
Clinical description: minor tissue loss. Salvageable with simple digital amputation (1 or 2 digits) or skin coverage.
2
Deeper ulcer with exposed bone, joint or tendon; generally not 
involving the heel; shallow heel ulcer, without calcaneal involvement
Gangrenous changes limited to digits
Clinical description: major tissue loss salvageable with multiple (3) digital amputations or
standard transmetatarsal amputation (TMA) ± skin coverage.
3
Extensive, deep ulcer involving forefoot and/or midfoot; 
deep, full thickness heel ulcer ± calcaneal involvement
Extensive gangrene involving forefoot and 
/or midfoot; full thickness heel necrosis 6 
calcaneal involvement
Clinical description: extensive tissue loss salvageable only with a complex foot reconstruction or non-traditional 
TMA (Chopart or Lisfranc); flap coverage or complex wound management needed for large soft tissue defect
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Ischemia 
Grade Ankle- Brachial Index
Ankle systolic pressure
(mmHg)
0  0.80 >100 60
1 0.6-0.79 70-100 40-59
2 0.4-0.59 50-70 30-39




No symptoms or signs of infection
Infection present, as defined by the presence of at least 2 of the following items:
• Local swelling or induration
• Erythema >0.5 to 2 cm around the ulcer
• Local tenderness or pain
• Local warmth
• Purulent discharge (thick, opaque to white, or sanguineous secretion)
1
Local infection involving only the skin and the subcutaneous tissue (without involvement of
deeper tissues and without systemic signs as described below).
Exclude other causes of an inflammatory response of the skin (e. g., trauma, gout, acute Charcot neuro- 
osteoarthropathy, fracture, thrombosis, venous stasis)
2
Local infection (as described above) with erythema >2 cm, or involving structures deeper than skin and 
subcutaneous tissues (e. g., abscess, osteomyelitis, septic arthritis, fasciitis), and
No systemic inflammatory response signs (as described below)
3
Local infection (as described above) with the signs of SIRS, as manifested by two or more of
the following:
• Temperature >38ºC or <36ºC
• Heart rate >90 beats/min
• Respiratory rate >20 breaths/min or PaCO2 <32 mm Hg
• White blood cell count >12,000 or <4000 cu/mm or 10% immature (band) forms
The leading pathogenetic factor in PAD is ischemia and 
surgical revascularization is the main way to the limb salvage.
In PAD/DF the foot revascularization is only a com-
ponent of comprehensive treatment in contrast to PAD. 
Adequate and timely debridement, control of infection, 
unloading of the affected parts of the foot, preservation of 
active support function of the foot are necessary to save 
the limb.
CLINICAL PURPOSE OF REVASCULARIZATION 
IN THE PAD/DF
The main purpose of revascularization is the Improv-
ing of Quality of Life (IQL). We defined IQL as sufficient 
distance of active walking, reduction of pain and healing 
of trophic disorders.
Limb salvage we defined not only as amputation-free 
survival, but also the saving of the supporting function of 
the foot without additional mobility devices (wheelchairs, 
crutches). This is the similar to the definition of Tefera et 
al. 2005 [13].
3. Healing of trophic disorders
2. Limb salvage
Improving of quality of life
TECHNICAL PURPOSE OF REVASCULARIZATION 
IN THE PAD/DF
In PAD and PAD/DF the main task is to increase 
blood flow to the limb.
In 2007 within the framework of the internation-
al consensus TASK-II, a classification of lesions of the 
arteries of the lower extremities was developed with rec-
ommendations for the use of surgical methods of revas-
cularization [14].
In patients with PAD/DF is important to direct blood 
flow to the one of foot arteries, preferably the artery that sup-
plies the lesion area – wound related revascularization [10].
Wound-related revascularization is possible due to 
the angiosome theory [15].
Angiosome- directed revascularization is directing of 
the blood flow to the affected area according to anatomical 
pattern of blood supply to the skin and subcutaneous tissue.
Adherence to the angiosomal concept can signifi-
cantly increase the likelihood of limb salvage and healing 
of trophic lesions in patients with PAD / DF [16,17,18].
Development of endovascular techniques allows to 
restore blood flow in the small arteries of the foot [19]. 
This can be achieved through the use of X-ray endovas-
cular techniques. Therefore in patients with PAD/DF an-
gioplasty is the first strategy in the world [20].
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OUR RESULTS OF REVASCULARIZATIONS IN PAD/DF.
Materials and methods
We analyzed results of 98 revascularizations of 77 
lower extremities in 74 patients in the period from 2014 
to 2019рр.
Males – 47 (59,5%), females – 30 (40,5%). Average 
age of patients – 68,4 р. All patients had trophic disorders 
of the foot (100%), in three of them – on the two lower 
extremities (4,1%). The most common type of lesions was 
focal necrosis or gangrene of the toes – 45 (58,4%). The 
second typical lesion was postoperative wounds that do 
not heal –11 (14,3%).
Planning of revascularization.
Indications for revascularization were considered to 
be trophic disorders of the lower extremity and the absence 
of pulsation of the arteries of the foot.
Details of occlusal- stenotic lesions and the possibility 
of using one of the methods of revascularization were deter-
mined using ultrasound performed on Mindray 5 and Sono-
ace R3. If the obtained data were insufficient for the choice 
of revascularization method, angiography was planned. An-
giography was performed on a Philips Alura F920.
Based on the obtained data, the optimal method of 
revascularization was chosen – X-ray endovascular angio-
plasty, open or hybrid. The feasibility of the chosen inter-
vention in each patient was assessed according to the «risk 
/ benefit» ratio [10].
First of all, we considered the possibility of angio-
plasty – «Angioplasty- first strategy». Other techniques 
were chosen with the predicted ineffectiveness of endo-
vascular intervention.
Open vascular surgery was planned in case of pre-
dicted ineffectiveness of angioplasty or inefficiency of pre-
vious endovascular intervention.
Hybrid interventions were chosen mainly for stenoses 
and occlusions of the tibial and foot arteries complicated 
by proximal or distal thrombosis.
Angioplasty, open and hybrid surgical techniques 
were used to restore blood supply.
Statistical analisys
The analysis of the research results was performed 
in the package EZR v.1.50 (R statistical software version 
4.0, R Foundation for Statistical Computing, Vienna, 
Austria) [21].
Results
Amputation-free survival during the year was 84,6%.
There was no statistically significant difference in the type of 
operation (p.value = 0.141).
Type 1 – angioplasty and hybrid revascularization.
Type 2 – open revascularization.
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Healing of the trophic disorders was 70,5% during the year.
There was also no statistically significant difference in the type of 
operation (p.value = 0.182).
Type 1 – angioplasty and hybrid revascularization.
Type 2 – open revascularization.
All types of operations were equally effective when following the 
algorithm for selecting the method of revascularization. This 
confirms the correct choice of technique in each case.
Wound-related revascularization
According to our data, adherence to the angiosomal 
theory increases the probability of preservation of the limb 
(p.value=0,939), but has almost no effect on the timing of 
healing (p.value=0,0118). The timing of healing in gen-
eral is very variable due to many factors that affect them.
Discussion
Revascularization in PAD/DF patients has different con-
sequences than in PAD. Restoration of blood flow in PAD / 
DF causes the activation of inflammation aimed at the rejec-
tion of necrotized infected tissues – reperfusion syndrome. The 
result may be an outbreak of purulent- septic processes with the 
spread of the fascial spaces of the foot, which is typical for di-
abetes. This requires active control of infection, debridement.
Elimination of nerve ischemia can lead to increased 
pain and reduces the running activity of the patient. At the 
same time, active dosed walking is a necessary component 
of maintaining the blood supply to the foot in the post-
operative period. Therefore, the treatment of neuropathy 
and analgesia plays an important role.
The need for debridement, off-loading with si-
multaneous active maintenance of foot support func-
tion, VAC-therapy, control of infection and increased 
local inflammation due to reperfusion syndrome requires 
a proper multidisciplinary approach to treatment after 
revascularization.
Conclusions:
The same treatment of PAD and PAD/DF pa-
tients leads to a large number of major amputations 
due to incorrect assessment of the consequences of 
revascularization.
At the diagnostic stage, patients with PAD and 
PAD / DF should be separated for creating the optimal 
treatment tactics.
The revascularization technique should be chosen 
taking into account the characteristics of the PAD/DF.
Different approach to the PAD/DF patients can im-
prove the results of revascularizations
Next research prospects:
Study of the revascularization results based on the 
differences between PAD and PD / DM can improve the 
treatment of these pathologies or prove the effectiveness 
of the overall approach.
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ОСОБЛИВОСТІ РЕВАСКУЛЯРИЗАЦІЇ НИЖНІХ КІНЦІВОК У ХВОРИХ НА ДІАБЕТИЧНУ СТУПНЮ
Д. Шаповалов, Ю. Гупало, В. Шапринський, А. Шамрай-Сас, А. Куцин, В. Гур’янов
Державна наукова установа «Науково-практичний центр профілактичної та клінічної медицини» Державного управління 
справами, Київ, Україна
Мета: Визначити особливості уражень периферичних артерій у пацієнтів з синдромом діабетичної сто-
пи, які слід враховувати при виборі метода реваскуляризації.
Вступ: Захворювання периферичних артерій у пацієнтів з синдромом діабетичної стопи (ЗПА/СДС) 
суттєво відрізняються за патогенезом, проявами та перебігом від суто атеросклеротичних уражень. Ці 
відмінності спричинили створення окремих класифікацій для визначення ступеню важкості захворюван-
ня. Однак підходи до реваскуляризації в обох випадках зазвичай залишаються однаковими. Вибір метода 
реваскуляризації з урахуванням особливостей ЗПА/СДС можуть покращити ефективність втручання.
Матеріали та методи: Ми проаналізували результати 98 реваскуляризацій 77 нижніх кінцівок у 74 пацієн-
тів за період з 2014 по 2019. Ангіопластика виконана в 72,3%, відкрите втручання – в 21,4%, гібридне – в 6,1%.
Результати. Показник виживання без ампутації протягом 1 року склав 84,6%, загоєння трофічних пору-
шень протягом 1 року – 70,5%.
Висновки. Ще на етапі діагностики пацієнти з ЗПА/CДС та ЗПА мають бути відокремлені для ство-
рення диференційованого лікування та окремого вибору методики реваскуляризації. Окремий підхід 
до пацієнтів з ЗПА/СДС може покращити результати реваскуляризації.
Ключові слова: захворювання периферичних артерій, синдром діабетичної стопи, ангіопластика, 
ангіосомно- спрямована реваскуляризація
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КЛІНІЧНА МЕДИЦИНА
Резюме
ОСОБЕННОСТИ РЕВАСКУЛЯРИЗАЦИИ НИЖНИХ КОНЕЧНОСТЕЙ У БОЛЬНЫХ С ДИАБЕТИЧЕСКОЙ СТОПОЙ
Д. Шаповалов, Ю. Гупало, В. Шапринский, А. Шамрай-Сас, А. Куцин, В. Гурьянов
Государственное научное учреждение «Научно-практический центр профилактической и клинической медицины» 
Государственного управления делами, Киев, Украина
Цель: определить особенности заболеваний периферических артерий у пациентов с синдромом диабе-
тической стопы, которые следует учитывать при выборе метода реваскуляризации.
Вступление: Заболевания периферических артерий у пациентов с синдромом диабетической стопы 
(ЗПА/СДС) существенно отличаются по патогенезу, проявлениям и течению от чисто атеросклероти-
ческих поражений. Эти особенности привели к созданию отдельных классификаций для определения 
степени тяжести заболевания. Подходы подходи к реваскуляризации в обоих случаях обычно остаются 
одинаковыми. зазвичай залишаються одинаковыми. Выбор методики реваскуляризации с учетом осо-
бенностей ЗПА/СДС могут улучшить эффективность вмешательства.
Материалы и методы: Мы проанализировали результаты 98 реваскуляризаций 77 нижних конечно-
стей у 74 пациентов за период с 2014 по 2019 гг. Ангиопластика выполнена в 72,3% случаев, открытое 
вмешательство – в 21,4%, гибридное – в 6,1%.
Результаты. Показатель выживания без ампутации на протяжении 1 года составил 84,6%, заживления 
трофических нарушений в течение 1 года – 70,5%.
Выводы. Еще на диагностическом этапе пациенты с ЗПА/CДС и ЗПА должны быть разделены для соз-
дания дифференцированного лечения отдельного выбора методики реваскуляризации. Отдельный под-
ход к пациентам с ЗПА/СДС может улучшить результаты реваскуляризации.
Ключевые слова: заболевания периферических артерий, синдром диабетической стопы, ангио-
пластика, ангиосомно- направленная реваскуляризация.
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